Leo Pharma IPO delay

Leo Pharma Considers Postponing IPO Amid Market Turmoil

Danish drugmaker Leo Pharma is considering delaying its planned IPO until 2027 due to ongoing global financial market turmoil. A company spokesperson declined to comment on the potential delay.